• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS THYROGLOBULIN ANTIBODY II REAGENT; IMMUNOCHEMICAL, THYROGLOBULIN AUTOANTIBODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS THYROGLOBULIN ANTIBODY II REAGENT; IMMUNOCHEMICAL, THYROGLOBULIN AUTOANTIBODY Back to Search Results
Catalog Number A32898
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/16/2015
Event Type  malfunction  
Manufacturer Narrative
A beckman coulter (bec) field service engineer (fse) was not dispatched to the customer's site.No hardware errors, flags or other assay issues were reported in conjunction with this event.There is no evidence that the access thyroglobulin antibody ii reagent was returned for evaluation.The customer sent the patient's sample to beckman coulter where testing was performed to evaluate the sample for interference.No interference was found.The sample was also was analyzed on a second methodology ((b)(4)) and recovered with a result above the assay's normal reference range.In conclusion, the cause of the event cannot be determined with the available information.
 
Event Description
The customer reported obtaining a normal thyroglobulin antibody (access thyroglobulin antibody ii) result for one (1) patient on the unicel dxi 800 access immunoassay system (serial number (b)(4)) that was discordant to another methodology.The initial access thyroglobulin antibody ii result was within the normal reference range of the assay.The customer analyzed the patient's sample on an alternate methodology ((b)(4)) and obtained a discordant, higher result above the assay's normal reference range.The access thyroglobulin antibody ii result was not reported outside the laboratory.There was no report of patient injury or change in patient treatment associated with this event.Beckman coulter (bec) cf originator recommended that the customer provide the patient sample for testing by the bec complaint handling unit (chu).Calibration, qc (quality control) and system check parameters were all recovering within expected ranges at the time of the event.Information on the collection and centrifugation of the patient sample was not supplied.There was no report of sample integrity issues reported by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS THYROGLOBULIN ANTIBODY II REAGENT
Type of Device
IMMUNOCHEMICAL, THYROGLOBULIN AUTOANTIBODY
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska 55318
Manufacturer Contact
jeffrey koll
1000 lake hazeltine drive
chaska 55318
MDR Report Key4953539
MDR Text Key23447464
Report Number2122870-2015-00458
Device Sequence Number1
Product Code JNL
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K062516
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Report Date 07/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2016
Device Catalogue NumberA32898
Device Lot Number438550
Was Device Available for Evaluation? No Information
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/30/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/01/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age51 YR
-
-